Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
Jinkai Zang(The Ohio State University), Zhong Huang(Shenzhen University), Bingjie Zhou, Shiqi Xu(Institut Pasteur of Shanghai), Dimitri Lavillette(Soochow University), Zhenghong Yuan(Shanghai Medical College of Fudan University), Yong Yang(Chinese Academy of Sciences), Rong Zhang(Huazhong Agricultural University), Chao Zhang(Fudan University), Youhua Xie(Shanghai Medical College of Fudan University), Chenjian Gu(Washington University in St. Louis), Hong Tang(Sichuan University), Lulu Bai(National Institute for Communicable Disease Control and Prevention), Di Qu(Xijing Hospital), Qiang Deng(Kunming University of Science and Technology)
Cited by 68
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
|Cell|2022|538
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530
Mxra8 is a receptor for multiple arthritogenic alphaviruses
|Nature|2018|455